Trademark: 88774070
Word
REPERTOIRE IMMUNE MEDICINES
Status
Registered
Status Code
700
Status Date
Tuesday, August 17, 2021
Serial Number
88774070
Registration Number
6457885
Registration Date
Tuesday, August 17, 2021
Mark Type
4000
Filing Date
Monday, January 27, 2020

Trademark Owner History
REPERTOIRE IMMUNE MEDICINES, INC. - Original Registrant
Cogen Immune Medicine, Inc. - Original Applicant

Classifications
5 therapeutic products for medical purposes in the nature of biological preparations, biological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations used to modulate an immune response; pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations in the nature of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system
"IMMUNE MEDICINES"

Trademark Events
Aug 17, 2021
Exparte Appeal Terminated
Aug 17, 2021
Registered-Supplemental Register
Jul 13, 2021
Law Office Publication Review Completed
Jul 12, 2021
Approved For Registration Supplemental Register
Jul 12, 2021
Teas/Email Correspondence Entered
Jul 12, 2021
Correspondence Received In Law Office
Jul 12, 2021
Assigned To Lie
May 27, 2021
Teas Response To Office Action Received
May 25, 2021
Teas Change Of Correspondence Received
May 25, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
May 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 12, 2021
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Feb 11, 2021
Notification Of Examiner's Amendment/Priority Action E-Mailed
Feb 11, 2021
Examiner's Amendment/Priority Action E-Mailed
Feb 11, 2021
Combined Examiner's Amendment/Priority Action Automatic Entry
Feb 11, 2021
Examiners Amendment And/Or Priority Action - Completed
Feb 11, 2021
Use Amendment Accepted
Feb 4, 2021
Amendment To Use Processing Complete
Feb 4, 2021
Use Amendment Filed
Feb 3, 2021
Teas Request For Reconsideration Received
Feb 3, 2021
Teas Amendment Of Use Received
Feb 3, 2021
Ex Parte Appeal-Instituted
Feb 3, 2021
Jurisdiction Restored To Examining Attorney
Feb 3, 2021
Exparte Appeal Received At Ttab
Aug 3, 2020
Notification Of Final Refusal Emailed
Aug 3, 2020
Final Refusal E-Mailed
Aug 3, 2020
Final Refusal Written
Jul 15, 2020
Teas/Email Correspondence Entered
Jul 14, 2020
Correspondence Received In Law Office
Jul 14, 2020
Teas Response To Office Action Received
Apr 21, 2020
Notification Of Non-Final Action E-Mailed
Apr 21, 2020
Non-Final Action E-Mailed
Apr 21, 2020
Non-Final Action Written
Apr 15, 2020
Assigned To Examiner
Apr 8, 2020
Automatic Update Of Assignment Of Ownership
Jan 30, 2020
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24